The neuropathophysiology of fecal incontinence (FI) is incompletely understood. We examined the efferent brain-anorectal and spino-anorectal motor-evoked potentials (MEP) to characterize the locus of neuronal injury in patients with FI.
F ecal incontinence (FI) affects 7%-15% of the western population. 1 Its pathophysiology is complex and multifactorial. 1 Previous studies using anal electromyography 2, 3 and pudendal nerve terminal motor latency assessment [4] [5] [6] [7] have suggested that neuropathy may play a role in causing FI.
Previously, we showed that rectal and anal motor evoked potential (MEP) latencies were significantly prolonged in patients with FI. 8 This finding indicates that the nerve conduction between the lumbosacral spinal cord and both the rectum and anus are significantly abnormal and indicative of neuropathy in patients with FI. Recently, a study using transcranial magnetic stimulation (TMS) 9 showed that 23% of patients with FI without known central neurologic disease or anal sphincter lesion had abnormal anal evoked pressure curves. This suggests that the abnormal conduction of efferent signals from the brain to the anus may also be abnormal in FI. However, whether the efferent conductivity between the brain and rectum is also abnormal in patients with FI is unknown. Also, the locus of neurophysiological dysfunction in patients with FI (ie, whether the neuropathy is confined to the peripheral nervous system or involves the brain-rectoanal, spinorectoanal, or brain-spinal nerve pathways) is unknown. A clear delineation of the locus of neuropathy may facilitate the use of targeted neuromodulation therapies. Previously, we showed the feasibility of performing simultaneous TMS and translumbar magnetic stimulation (TLMS) and transsacral magnetic stimulation (TSMS) in the same individual. 8, 10 Such an analysis could provide comprehensive information regarding the descending brain-anorectal axis, and help to dissect out the precise loci of neuropathy in patients with FI (ie, if it affects the central or peripheral nervous system or both).
In this study, we tested the hypothesis that the neural conduction between the brain and anorectum is deranged in patients with FI. Our aim was to examine the locus of neuropathy in patients with FI by performing bilateral TMS, TLMS, and TSMS simultaneously and evaluating the rectal and anal MEPs and to compare these findings with healthy control subjects.
Materials and Methods

Subjects
Patients with FI with at least 1 episode of formed or liquid stool leakage per week, as demonstrated on a prospective stool diary, and no previous history of back injury, spinal surgery, or neurologic disease were enrolled in this study. Healthy subjects were screened with Mayo questionnaire, and those without previous surgery or medication use (except oral contraceptives, aspirin, or multivitamins) and a normal physical examination were recruited. The study protocol was approved by the institutional review boards at the Augusta University (No. 619411-17) and University of Iowa (No. Pro 00000245), and were registered at Clinical trial. gov (NCT02556151).
Experimental Design
Each subject underwent magnetic stimulations at 3 different sites (transcranial [TMS] , translumbar [TLMS] , and transsacral [TSMS]) in a random order after a rest period of 30 minutes. The MEPs were recorded simultaneously from the rectum and anal region using an anal probe. Each test took about 30 minutes to complete. Subsequently, all subjects underwent highresolution anorectal manometry. Additionally, patients with FI filled out questionnaires that assessed the severity and impact of FI including the FI Severity Index (FISI) 11 and the FI Severity Score (FISS). 12 The FISI score assessed the frequency of different types of stool leakage (gas/mucus/liquid stool/solid stool) with scores ranging from 4 to 24 (no leakage). FISS culls the information on the composition, frequency, amount, and the patients' feelings about the stool leakage. The severity scores range from 5 (mild) to 20 (severe leakage). Overall severity of FI was assessed on a visual analog scale as 0 (absent) to 10 (very severe).
Transcranial Magnetic Stimulation, Translumbar Magnetic Stimulation, and Transsacral Magnetic Stimulation
With the subject lying in the left lateral position, a probe containing 2 pairs of bipolar steel ring electrodes (Gaeltec, Gaeltec Devices Ltd, Dunvegan, Scotland) was placed such that 1 pair was located in the anal canal at 2-3 cm from the anal verge and the other pair was located in the rectum at 7-9 cm from the anal verge. The probe was fixed using latex-free tape (3M, St. Paul, MN), and electrically grounded by placing a surface electrode on the gluteal muscle. Also, 3 surface electrodes were placed on anterior tibialis muscle. The magnetic stimulations were performed using the Magstim Rapid 2 stimulator (The Magstim Company Limited, Whiteland, Wales, UK). TMS was performed with a cone-shaped coil and TLMS and TSMS was performed with a 90-mm circular coil (The Magstim Company Limited). Subjects
What You Need to Know
Background Fecal incontinence (FI) is a common clinical problem with a multifactorial etiology. Peripheral spinoanorectal neuronal dysfunction may predispose patients to fecal incontinence. We performed simultaneous examination of the bilateral, efferent cortico-anorectal, and spino-anorectal motor evoked potentials (MEPs) to evaluate the presence of and locus of neuronal injury in patients with FI.
Findings
Neuronal conduction was normal between the cortex and spinal cord, but it was abnormal and prolonged between the lumbar spinal nerve roots and the rectum and anus bilaterally, and likewise between the sacral spinal nerve roots and the rectum and anus, in 93% of measurements from patients with FI.
Implications for patient care
Peripheral lumbosacral neuropathy is common and could be an important pathophysiological dysfunction in FI patients. Trans-lumbosacral anorectal magnetic stimulation (TAMS) is a non-invasive and safe test for the evaluation and objective confirmation of an underlying neuropathy. It is important to validate these findings, which could have implications for management of patients with FI-especially use of neuromodulation therapies.
were semirecumbent (30-degree elevation) for the TMS study and prone for the TLMS and TSMS studies.
The corticorectal and corticoanal MEPs were evoked by stimulating the brain bilaterally around the supermedial motor cortex (Brodmann area 4). 10, 13, 14 For the TLMS, the coil was applied on each side at the L3 level, about 4 cm lateral to the midline. For the TSMS the coil was applied on each side at the S3 level, about 4 cm lateral to the midline. 8 Typically, the magnetic stimulations began at 50% and thereafter in increments of 5% up to 90% until an adequate and reproducible MEP response, defined as an anal and rectal MEP response of 10 mV and an anterior tibialis MEP of 20 mV with 50% of trials was obtained. At least 5 MEP responses were recorded at each site.
Definition of Terms and Data Analysis
Motor evoked potentials. The MEP data were analyzed manually using the Neuropack (Nihon Kohden, Tokyo, Japan) software. The MEP latency was defined as the interval between the onset of stimulus and the onset of the individual rectal or anal MEP waveform 8 and was expressed in milliseconds ( Figure 1 ). The mean value of the 5 MEP responses per site was calculated as the MEP response for that site. An abnormal MEP latency was defined as a value higher than the 95% confidence interval of healthy control subjects. 
High-Resolution Anorectal Manometry and Rectal Sensory Assessment
High-resolution anorectal manometry was performed by placing into the anorectum a 12-sensor circumferential solid-state probe (ManoScan AR Catheter, Medtronics, MN) with a 4-cm-long balloon. Details of the manometric methods have been described previously. 15, 16 Anal sphincter pressures at rest, during squeeze, and when pushing were measured. The sensory thresholds for first sensation, desire to defecate, urge to defecate, and the maximum tolerable volume were recorded. 17 Rectal compliance was evaluated with the rectal pressures at different volumes of distention. 17 
Correlation of Motor Evoked Potential Latency With Demographic and Anorectal Physiology and Structure
To assess these associations, we measured the relationship between age, gender, ethnicity, history of anorectal injuries, and anal sphincter function and anal sphincter defects, FISI and FISS scores, and the rectal and anal MEP latencies.
Statistical Analysis
Data were expressed as mean AE standard error of the mean. Mann-Whitney U test was used to compare the differences of age, FISI and FISS scores, MEP latencies, and the number of abnormal latency sites at the rectal and anal sites between patients with and without rectal and anal trauma (surgery and obstetric), of different gender and ethnicity. Kruskal-Wallis test was used to compare the differences of age, FISI and FISS scores, MEP latencies, and the number of abnormal latency sites at the rectal and anal sites among patients with different types of FI. Analysis of covariance test was used for the comparison of MEP latencies between patients with FI and control subjects to adjust the effect of age and body mass index (BMI). Multiple linear regression analysis was used to assess the association between the anal sphincter pressures and MEP latencies (the effect of age and BMI was adjusted). Logistic regression analysis was used to assess the association between the occurrence of internal anal sphincter and external anal sphincter defect and the MEP latencies (the effect of age and BMI was adjusted). A P value of <.05 was considered statistically significant. 2 ). The patients with FI were older (P < .001) and heavier (P ¼ .001) than control subjects. The gender distribution was similar (P ¼ .636).
Results
Subjects
Demographics
Predisposing and other demographic and key manometric and morphologic features are summarized in Supplementary Tables 1 and 2 . The median number of pregnancies in the patients with FI was 2 (range, 1-5), whereas the median number of pregnancies in control subjects was 1 (range, 1-4; P < .05). The obstetric history of patients with FI is summarized in Supplementary Table 1. All controls had vaginal deliveries, and 2 also had cesarean section. Five control subjects reported vaginal tears and 2 had difficult labor that required forceps-assisted delivery. Based on the predominant type of FI, 25.9% (7/27) patients were categorized as passive FI, 55.6% (15/27) patients as urge FI, and 18.5% (5/27) as both passive and urge FI. 
Anorectal Manometry
Transcranial Motor Evoked Potentials
Typical profiles of the MEP response in a patient with FI and a healthy control subject are shown in Figure 1 . Abnormal MEP responses were seen in 22 patients with FI (81.5%). Seven patients (25.9%) had abnormal MEPs at all sites, and on both sides (Figure 2) .
Four separate MEP responses were obtained for each subject, and the mean TMS data for both the patients with FI and control subjects are summarized in Table 1 . The MEP latencies at both the anal and rectal recording sites, and at both the left and the right sides, were significantly prolonged in patients with FI compared with control subjects (P < .05) except right anal MEP. Only 5 patients (18.5%) with FI had normal MEP responses at both sites and on both sides. 
Translumbar/Transsacral Motor Evoked Potentials
Eight separate MEP responses were obtained. Figure 3 shows typical MEP profiles of the TLMS and TSMS responses in a patient with FI and a healthy control subject. Table 2 summarizes the comparison of the MEP latencies between patients with FI and healthy control subjects. Overall, the MEP latencies obtained with both the TLMS and TSMS were significantly prolonged (most P < .01) in patients with FI. Only 2 patients had normal MEP response for both the TLMS and TSMS. Most patients had abnormal MEP responses at both the anal and rectal sites (Figure 2 ).
Corticolumbar and Corticosacral Conduction Time
Eight separate corticolumbar and corticosacral conduction times were obtained. There was no difference in the corticolumbar spinal and corticosacral spinal conduction time between the patients with FI and control subjects, and on both sides ( Table 1) . We found that age, FISI and FISS scores, and the MEP latencies at the rectal and anal sites were similar between black and white persons, men and women, and whether patients had urge or passive type of FI (Table 3) . There was a trend toward higher MEP latencies in women, but only left lumborectal MEP was significantly prolonged (P ¼ .034), and the overall number of abnormal sites were comparable. Patients with a history of anorectal trauma (surgery, obstetric injury) had significantly more severe leakage (higher FISS score) (P ¼ .001) ( Table 3 ). There was no association between the anal resting and squeeze pressure and bilateral MEPs (P > .05). Also, there was no significant correlation between the external and internal anal sphincter defects and bilateral MEP latencies (P > .05).
Correlations of Motor Evoked
Discussion
In this comprehensive investigation of the efferent brain, spinal cord, and pelvic floor nerve conduction using MEPs, we found that most patients with FI exhibit anorectal neuropathy that affects the corticoanorectal and spinoanorectal efferent pathways. Further analysis revealed that the corticospinal segment was mostly intact because there was no difference in the spinal conduction time between the patients with FI and control subjects, whereas, the neuropathy primarily affected the lumborectal, lumboanal, sacrorectal, and sacroanal nerves. We also found that the neuropathy involves both the rectum and anus regions in about one-half of patients. This finding underscores the importance of evaluating neuronal function in patients with FI, and that lumbar and sacral neuropathy could play an important role alongside other factors in the pathogenesis of FI.
TMS is routinely used for neurophysiological evaluation. 18, 19 Recently, it has been used for the assessment of anal sphincter 9, 20, 21 and rectum. 21 These studies were mostly exploratory and involved healthy control subjects, and used electromyography and evoked pressure techniques. To our knowledge, there has been only 1 other study of motor response of the anal sphincter in patients with FI using TMS. 9 They found that 23% of patients with FI had abnormal evoked pressure latencies, and had significantly lower voluntary contraction amplitudes, and significantly higher rectal sensory thresholds than healthy control subjects. However, there was no statistical difference between the evoked pressure curves of healthy subjects and patients with FI. Moreover, they did not assess the rectal or spinal evoked responses. Unlike their study, we used the MEP, which is a direct and reproducible measurement of the neuroelectric signal, that not only detects neuropathy but also quantifies it objectively. 10 In contrast, evoked anal pressure curve is an indirect and less precise measure of nerve and muscle function.
Both the TMS and TLMS and TSMS tests were well tolerated with no adverse effect during the study. Our data show that there is no difference in the neural signal conduction time between the cortex and the lumbar or sacral spinal cord. Thus, the abnormal conduction time from the lumbar and sacral spinal cord to the rectum and anus is the main reason for the prolonged conduction time between the cortex to the rectum and/or the anus. Our findings not only corroborated previous studies 8, 22 but further extended those observations that although there is evidence of corticoanorectal neuropathy, the primary locus for the delayed conduction is the peripheral spinoanorectal pathway and not central. This peripheral spinoanorectal neuropathy most likely stems from nerve damage caused by the obstetrical injury, occult neural injury (twisting of pelvis/spine), diabetes, and other back and pelvic floor surgeries. Overall, we found that 1 or more of the 8 MEP latencies we measured in each patient were abnormal in 93% of patients with FI, and is similar to a prevalence of 87% reported previously. 8 Also, we found that the abnormal MEP latencies obtained with both the TMS, TLMS and TSMS at a single site (anal or rectal) in patients with FI ranges from 20% to 40%, and at 2 sites (anal and rectal) from about 50% to 60%. These results suggest that neuropathy is patchy and affects different nerve pathways in different patients. This finding is important and emphasizes that in routine clinical practice, TLMS and TSMS is quite sensitive and can provide objective and comprehensive information regarding the underlying neuropathy.
Also, we found that the MEP latencies and the prevalence of abnormal MEP test in patients with FI were not associated with age, gender, ethnicity (black vs white persons), type of FI (urge or passive), anal resting or squeeze sphincter pressures, or sphincter defects. About 30% of patients in this study were men, and although the precise reason for their neuropathy is unclear, almost all had weak anal sphincters, 4 had sphincter defects, and 7 of 8 had sensory dysfunction (rectal hypersensitivity or hyposensitivity). In contrast, female patients with a history of anorectal trauma (obstetric or surgery) had more severe leakage as measured by FISS. These findings suggest that anorectal neuropathy is an independent risk factor in the pathogenesis of FI, but this requires further validation.
FI is a multifactorial dysfunction that involves anal sphincter dysfunction; puborectalis dysfunction; rectal hypersensitivity or hyposensitivity; impaired rectal compliance; diarrhea with irritants, such as bile salts; and neuropathy among others. Also, some factors are related, such as if the rectal compliance is impaired, then the rectal hypersensitivity is secondary to impaired rectal compliance. In our study, patients designated as hypersensitive had normal rectal compliance. Also, we found that although neuropathy could overlap with manometric or sensory dysfunctions, it may not correlate with other abnormalities and therefore is an independent risk factor. Identifying neuropathy may facilitate novel therapies, such as repetitive magnetic stimulation 23 for treatment of FI. Recently, we showed that translumbosacral neuromodulation therapy at 1-Hz frequency significantly reverses/improves lumbosacral neuropathy and decreases FI episodes possibly through neuromodulation and neuroplasticity. 24 The limitations of our study include the smaller sample size of patients with FI, who were older, with higher BMI than our control subjects. Also, our patients were evaluated in a tertiary care center, and possibly had more advanced FI than seen in community practice. However, the methodology test has been validated, and the data are similar to a previous study 8 confirming these observations. In conclusion, most patients with FI demonstrate neuropathy that primarily affects the peripheral nervous system, chiefly the lumbar and sacral nerves that innervate the anus and rectum, with an intact corticospinal segment. Translumbosacral anorectal magnetic stimulation (TAMS) is a useful, noninvasive, and comprehensive test for detecting neuropathy in FI and reveals segmental neuropathophysiological dysfunction in FI. Delineation of the specific neuronal pathways and sites that are abnormal could pave the way for the development of targeted treatments using biofeedback, sacral nerve stimulation, repetitive magnetic stimulation, and translumbosacral neuromodulation therapy.
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